Similar Articles

Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?

Rezan Koçak Ulucaköy, Ayza Kılıç, Sevilay Batıbay, İdil Melis Çobanoğlu, Elif Nur Yıldırım Öztürk, Zafer Günendi, Aylin Sepici Dinçel, Feride Nur Göğüş

DOI: 10.46497/ArchRheumatol.2024.10360

Issue: Online First
0 438

Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results

Sadettin Uslu, Semih Gülle, Özkan Urak, Gerçek Şen, Ediz Dalkılıç, Soner Şenel, Servet Akar, Nevsun İnanç, Ayşe Cefle, Aydan Köken Avşar, Servet Yolbaş, Sema Yılmaz, Özgül Soysal Gündüz, İsmail Sarı, Merih Birlik, Nurullah Akkoç, Fatoş Önen

DOI: 10.46497/ArchRheumatol.2024.10391

Issue: Online First
0 466

Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study

Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2024.10562

Issue: Online First
0 2

Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus

Lingyan He, Mingming Yan, Rui Wen, Jiali Li

DOI: 10.46497/ArchRheumatol.2024.9977

Issue: Volume 39 - Issue 2 - June 2024
0 0